Novel autophagic vacuolar myopathies: Phenotype and genotype features

Filomena Napolitano1,2, Chiara Terracciano1,3, Giorgia Bruno1

  • 1Department of Advanced Medical and Surgical Sciences, 2nd Division of Neurology, Center for Rare Diseases and Inter University Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Abstract

Insights

Autophagic vacuolar myopathies (AVMs) are a group of muscle disorders. Whole exome sequencing revealed novel gene mutations in patients with AVMs, suggesting impaired autophagy can reduce GAA activity.

Area of Science:

  • Neurology
  • Genetics
  • Cell Biology

Background:

  • Autophagic vacuolar myopathies (AVMs) are a heterogeneous group of muscle disorders characterized by autophagic vacuoles.
  • Glycogen storage disease type II (GSDII), caused by lysosomal acid α-glucosidase (GAA) deficiency, is a well-characterized AVM.

Purpose of the Study:

  • To investigate the mutational profile of seven neuromuscular patients with clinical, myopathological, and biochemical similarities to AVMs.
  • To explore the genetic underpinnings of AVMs beyond known GAA mutations.

Main Methods:

  • A diagnostic protocol for late-onset GSDII (LO-GSDII) was applied, including PAS-positive lymphocyte counts, DBS-GAA assays, muscle biopsy analysis, and GAA sequencing.
  • Whole exome sequencing (WES) was employed to identify genetic variations in patients negative for pathogenic GAA mutations.

Main Results:

  • Patients presented with limb girdle-like muscle weakness, hyperCKaemia, vacuolated PAS-positive lymphocytes, glycogen accumulation, and impaired autophagy.
  • While GAA sequencing revealed no mutations, WES identified novel mutations in genes involved in the lysosomal-autophagic pathway.
  • Decreased GAA activity was observed, correlating with impaired autophagy.

Conclusions:

  • Reduced GAA activity can occur in conditions of impaired autophagy, highlighting a broader connection than previously understood.
  • WES is recommended for genetically undefined AVM cases to uncover novel genetic causes.
  • PAS-positive lymphocytes and decreased GAA activity are potential biomarkers for AVMs, alongside autophagic vacuoles.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
158